Cargando…

Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation

Postoperative adhesion formation often ruins the quality of life or is an obstacle to illnesses with curative operation such as cancer. Previously we demonstrated that interferon-γ-promoted fibrin deposition drove postoperative adhesion formation. However, its underlying cellular and molecular mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Uyama, Naoki, Tsutsui, Hiroko, Wu, Songtao, Yasuda, Koubun, Hatano, Etsuro, Qin, Xian-Yang, Kojima, Soichi, Fujimoto, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879753/
https://www.ncbi.nlm.nih.gov/pubmed/31772282
http://dx.doi.org/10.1038/s41598-019-54175-1
_version_ 1783473665884553216
author Uyama, Naoki
Tsutsui, Hiroko
Wu, Songtao
Yasuda, Koubun
Hatano, Etsuro
Qin, Xian-Yang
Kojima, Soichi
Fujimoto, Jiro
author_facet Uyama, Naoki
Tsutsui, Hiroko
Wu, Songtao
Yasuda, Koubun
Hatano, Etsuro
Qin, Xian-Yang
Kojima, Soichi
Fujimoto, Jiro
author_sort Uyama, Naoki
collection PubMed
description Postoperative adhesion formation often ruins the quality of life or is an obstacle to illnesses with curative operation such as cancer. Previously we demonstrated that interferon-γ-promoted fibrin deposition drove postoperative adhesion formation. However, its underlying cellular and molecular mechanisms remain poorly understood. We found that myofibroblasts of the adhesion predominantly expressed signature molecules of mesothelial cells that line the serosa. Microarray analysis revealed IL-6 as a key underlying player, supported by elevated IL-6 levels in the peritoneal fluid of post-laparotomy human subjects. Injured serosa of cecum-cauterized mice also exhibited induction of Il6, which was followed by Tnf, concomitant with rapid accumulation of neutrophils, substantial population of which expressed TGF-β1, a master regulator of fibrosis. Besides, neutrophil-ablated mice showed reduction in induction of the adhesion, suggesting that TGF-β1(+)neutrophils triggered the adhesion. Human neutrophils expressed TGFB1 in response to TNF-α and TNF in response to IL-6. Moreover, anti-IL-6 receptor monoclonal antibody abrogated neutrophil recruitment and adhesion formation. Thus, IL-6 signaling represents a potential target for the prevention of postoperative adhesions.
format Online
Article
Text
id pubmed-6879753
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68797532019-12-05 Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation Uyama, Naoki Tsutsui, Hiroko Wu, Songtao Yasuda, Koubun Hatano, Etsuro Qin, Xian-Yang Kojima, Soichi Fujimoto, Jiro Sci Rep Article Postoperative adhesion formation often ruins the quality of life or is an obstacle to illnesses with curative operation such as cancer. Previously we demonstrated that interferon-γ-promoted fibrin deposition drove postoperative adhesion formation. However, its underlying cellular and molecular mechanisms remain poorly understood. We found that myofibroblasts of the adhesion predominantly expressed signature molecules of mesothelial cells that line the serosa. Microarray analysis revealed IL-6 as a key underlying player, supported by elevated IL-6 levels in the peritoneal fluid of post-laparotomy human subjects. Injured serosa of cecum-cauterized mice also exhibited induction of Il6, which was followed by Tnf, concomitant with rapid accumulation of neutrophils, substantial population of which expressed TGF-β1, a master regulator of fibrosis. Besides, neutrophil-ablated mice showed reduction in induction of the adhesion, suggesting that TGF-β1(+)neutrophils triggered the adhesion. Human neutrophils expressed TGFB1 in response to TNF-α and TNF in response to IL-6. Moreover, anti-IL-6 receptor monoclonal antibody abrogated neutrophil recruitment and adhesion formation. Thus, IL-6 signaling represents a potential target for the prevention of postoperative adhesions. Nature Publishing Group UK 2019-11-26 /pmc/articles/PMC6879753/ /pubmed/31772282 http://dx.doi.org/10.1038/s41598-019-54175-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Uyama, Naoki
Tsutsui, Hiroko
Wu, Songtao
Yasuda, Koubun
Hatano, Etsuro
Qin, Xian-Yang
Kojima, Soichi
Fujimoto, Jiro
Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
title Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
title_full Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
title_fullStr Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
title_full_unstemmed Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
title_short Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
title_sort anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879753/
https://www.ncbi.nlm.nih.gov/pubmed/31772282
http://dx.doi.org/10.1038/s41598-019-54175-1
work_keys_str_mv AT uyamanaoki antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT tsutsuihiroko antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT wusongtao antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT yasudakoubun antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT hatanoetsuro antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT qinxianyang antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT kojimasoichi antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation
AT fujimotojiro antiinterleukin6receptorantibodytreatmentamelioratespostoperativeadhesionformation